Notify me when Kaupinen Wes files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| PVLA | PALVELLA THERAPEUTICS, INC. | Common Stock, $0.001 par value per share | 15% | $39,443,959 | 1,644,869 | Kaupinen Wes | 13 Dec 2024 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|